Creating Biomedical Technologies to Improve Health

RESEARCH FUNDING

FY 2017 Financial Management Plan

GRANTS MECHANISM PERCENTILE PAYLINE (see notes below for superscripts) ADMINISTRATIVE BUDGET REDUCTION
R01 16%1

10% reduction
Limited to 4 years

Expanded Opportunity Zone (EOZ) 30%2 Negotiated
Parent/ERBG R21 Select Pay3 No reduction
Trailblazer R21 Select Pay4 No reduction
R15, R03 16% No reduction
P41 Select Pay5 No reduction
U01 Select Pay5 10% reduction
Limited to 4 years
(BRP U01s-no reduction, limited to 5 years)
F32, F33, T32, K01, K08, K23, K24, K25, K99/R00, SBIR, STTR Select Pay6 No reduction

Notes:

1 The percentile payline for new investigators is 5% higher, i.e. 21%. See policy at https://www.nibib.nih.gov/news-events/newsroom/nibib-funding-policy-supports-new-investigators

2 The Expand Opportunity Zone (EOZ) is approximated twice the payline. Applications within the EOZ may be selected for funding based on the criteria outlined at  https://www.nibib.nih.gov/research-funding/expanded-opportunity-zone . The EOZ for R01 and R03 applications is from the 17th to the 30th percentile. For new investigator applications, the EOZ is from the 22nd to the 35th percentile. The EOZ for R21 applications is up to 18%.

3The NIBIB implemented a new policy for R21s beginning in FY17. As part of the new policy, R21 funding is based on programmatic considerations. See Guide Notice at https://grants.nih.gov/grants/guide/notice-files/NOT-EB-16-009.html. Please note that for FY18 there is a new NIBIB R21 FOA at https://grants.nih.gov/grants/guide/pa-files/PAR-17-441.html which has replaced NIBIB participation on the Parent R21 FOA (https://grants.nih.gov/grants/guide/pa-files/PA-16-161.html and the EBRG FOA https://grants.nih.gov/grants/guide/pa-files/PA-16-040.html.

4The NIBIB Trailblazer R21 is a new initiative for New and Early Stage Investigators. Trailblazer funding is based on programmatic considerations.  Read more at  https://grants.nih.gov/grants/guide/pa-files/PAR-16-390.html

5No fixed payline exists for P41 and U01 awards. Applications are considered on a case-by-case basis based on programmatic considerations. Bioengineering Research Partnership (BRP) U01s do not receive any administrative cuts.

6No fixed payline exists for F, K, T32, SBIR and STTR grants. A limited number of awards are available for highly meritorious applications. Funding decisions are also based on programmatic considerations and available funds.